---
figid: PMC6467965__fimmu-10-00752-g0002
figlink: /pmc/articles/PMC6467965/figure/F2/
number: Figure 2
caption: Schematic presentation of the cytotoxic pathways, induced in cancer cells
  by the complement C5b-9, the counteractive cellular resistance mechanisms, and postulated
  approaches to overcome this cancer evasion. Following the binding of antibodies
  to cancer cells, the complement system is activated and deposits C4b and C3b molecules
  that serve as initiators of C3/C5 convertase activation. The C5 convertases initiate
  the activation of the terminal complement pathway and the formation of the C5b-9
  complexes (). Upon insertion of the C5b-9 complexes into the plasma membrane of
  cancer cells, they induce calcium ion influx and activate pro- and anti-lytic signals.
  This scheme depicts the proteins proposed to be involved in the ensuing cancer cell
  death (encircled) and the proteins protecting the cancer cells from the lytic processes.
  Extracellular (gray boxes) and intracellular (purple boxes) protective proteins
  are indicated. Several reagents (white boxes) that will block the protective proteins
  are indicated and proposed for adjuvant therapy to therapeutic antibodies. Ab, antibody;
  Bcl-2, B-cell lymphoma/leukemia-2; BH3, Bcl-2 homolog domain-3; Bid, BH3 interacting
  domain death agonist; CK2, casein kinase 2; ERK, extracellular signal-regulated
  kinase; HSP90, heat shock protein 90; HSP70, heat shock protein 70; JNK, c-jun N-terminal
  kinase; MAC, complement membrane attack complex; MLKL, mixed lineage kinase domain-like
  protein; MMP, matrix metalloproteinase; PKC, protein kinase C; RIPK1, receptor-interacting
  protein kinase 1; RIPK3, receptor-interacting protein kinase 3; serine-, serine
  protease; siRNA, small interfering RNA.
pmcid: PMC6467965
papertitle: 'Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions,
  and Approaches for Intervention.'
reftext: Zvi Fishelson, et al. Front Immunol. 2019;10:752.
pmc_ranked_result_index: '119640'
pathway_score: 0.9230992
filename: fimmu-10-00752-g0002.jpg
figtitle: Schematic presentation of the cytotoxic pathways, induced in cancer cells
  by the complement C5b-9, the counteractive cellular resistance mechanisms, and postulated
  approaches to overcome this cancer evasion
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6467965__fimmu-10-00752-g0002.html
  '@type': Dataset
  description: Schematic presentation of the cytotoxic pathways, induced in cancer
    cells by the complement C5b-9, the counteractive cellular resistance mechanisms,
    and postulated approaches to overcome this cancer evasion. Following the binding
    of antibodies to cancer cells, the complement system is activated and deposits
    C4b and C3b molecules that serve as initiators of C3/C5 convertase activation.
    The C5 convertases initiate the activation of the terminal complement pathway
    and the formation of the C5b-9 complexes (). Upon insertion of the C5b-9 complexes
    into the plasma membrane of cancer cells, they induce calcium ion influx and activate
    pro- and anti-lytic signals. This scheme depicts the proteins proposed to be involved
    in the ensuing cancer cell death (encircled) and the proteins protecting the cancer
    cells from the lytic processes. Extracellular (gray boxes) and intracellular (purple
    boxes) protective proteins are indicated. Several reagents (white boxes) that
    will block the protective proteins are indicated and proposed for adjuvant therapy
    to therapeutic antibodies. Ab, antibody; Bcl-2, B-cell lymphoma/leukemia-2; BH3,
    Bcl-2 homolog domain-3; Bid, BH3 interacting domain death agonist; CK2, casein
    kinase 2; ERK, extracellular signal-regulated kinase; HSP90, heat shock protein
    90; HSP70, heat shock protein 70; JNK, c-jun N-terminal kinase; MAC, complement
    membrane attack complex; MLKL, mixed lineage kinase domain-like protein; MMP,
    matrix metalloproteinase; PKC, protein kinase C; RIPK1, receptor-interacting protein
    kinase 1; RIPK3, receptor-interacting protein kinase 3; serine-, serine protease;
    siRNA, small interfering RNA.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKCA
  - MLKL
  - MAPK1
  - PRKCD
  - PRKD3
  - MMP7
  - MMP24
  - PRKCB
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - C7
  - MAPK3
  - MMP3
  - MMP21
  - MMP2
  - MMP12
  - MMP11
  - MMP10
  - MMP9
  - MMP8
  - CD46
  - CD55
  - CD59
  - PRKCZ
  - C6
  - MMP15
  - MMP14
  - MMP13
  - HSP90AB1
  - MAPK10
  - MAPK9
  - MAPK8
  - C5
  - C9
  - C8G
  - C8A
  - C8B
  - BID
  - C3
  - MMP16
  - CSNK2B
  - HSPA9
  - TRAP1
  - HSP90B1
  - MMP1
  - MMP20
  - MMP23B
  - MMP28
  - MMP25
  - MMP27
  - MMP19
  - RIPK3
  - CSNK2A2
  - MMP17
  - CSNK2A1
  - Serine
  - Sialic acid
  - Ca
  - Cavcolin
  - cancer
genes:
- word: PKC/ERKinhibitor
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: MLKL
  symbol: MLKL
  source: hgnc_symbol
  hgnc_symbol: MLKL
  entrez: '197259'
- word: PKC/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PKC/ERKinhibitor
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC/ERKinhibitor
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: (Cathepsin,MMP,Serine-)
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP7
  entrez: '4316'
- word: (Cathepsin,MMP,Serine-)
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP24
  entrez: '10893'
- word: PKC/ERKinhibitor
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC/ERKinhibitor
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC/ERKinhibitor
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC/ERKinhibitor
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC/ERKinhibitor
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC/ERKinhibitor
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: MAC
  symbol: MAC
  source: bioentities_symbol
  hgnc_symbol: C7
  entrez: '730'
- word: PKC/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: (Cathepsin,MMP,Serine-)
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP3
  entrez: '4314'
- word: (Cathepsin,MMP,Serine-)
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP21
  entrez: '118856'
- word: (Cathepsin,MMP,Serine-)
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP2
  entrez: '4313'
- word: (Cathepsin,MMP,Serine-)
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP12
  entrez: '4321'
- word: (Cathepsin,MMP,Serine-)
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP11
  entrez: '4320'
- word: (Cathepsin,MMP,Serine-)
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP10
  entrez: '4319'
- word: (Cathepsin,MMP,Serine-)
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP9
  entrez: '4318'
- word: (Cathepsin,MMP,Serine-)
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP8
  entrez: '4317'
- word: CD46,
  symbol: CD46
  source: hgnc_symbol
  hgnc_symbol: CD46
  entrez: '4179'
- word: CD55,
  symbol: CD55
  source: hgnc_symbol
  hgnc_symbol: CD55
  entrez: '1604'
- word: CD59
  symbol: CD59
  source: hgnc_symbol
  hgnc_symbol: CD59
  entrez: '966'
- word: PKC/ERKinhibitor
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: MAC
  symbol: MAC
  source: bioentities_symbol
  hgnc_symbol: C6
  entrez: '729'
- word: (Cathepsin,MMP,Serine-)
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP15
  entrez: '4324'
- word: (Cathepsin,MMP,Serine-)
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP14
  entrez: '4323'
- word: (Cathepsin,MMP,Serine-)
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP13
  entrez: '4322'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90AB1
  entrez: '3326'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAC
  symbol: MAC
  source: bioentities_symbol
  hgnc_symbol: C5
  entrez: '727'
- word: MAC
  symbol: MAC
  source: bioentities_symbol
  hgnc_symbol: C9
  entrez: '735'
- word: MAC
  symbol: MAC
  source: bioentities_symbol
  hgnc_symbol: C8G
  entrez: '733'
- word: MAC
  symbol: MAC
  source: bioentities_symbol
  hgnc_symbol: C8A
  entrez: '731'
- word: MAC
  symbol: MAC
  source: bioentities_symbol
  hgnc_symbol: C8B
  entrez: '732'
- word: Bid
  symbol: BID
  source: hgnc_symbol
  hgnc_symbol: BID
  entrez: '637'
- word: C3
  symbol: C3
  source: hgnc_symbol
  hgnc_symbol: C3
  entrez: '718'
- word: (Cathepsin,MMP,Serine-)
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP16
  entrez: '4325'
- word: CK2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2B
  entrez: '1460'
- word: GRP75
  symbol: GRP75
  source: hgnc_alias_symbol
  hgnc_symbol: HSPA9
  entrez: '3313'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: TRAP1
  entrez: '10131'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90B1
  entrez: '7184'
- word: (Cathepsin,MMP,Serine-)
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP1
  entrez: '4312'
- word: (Cathepsin,MMP,Serine-)
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP20
  entrez: '9313'
- word: (Cathepsin,MMP,Serine-)
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP23B
  entrez: '8510'
- word: (Cathepsin,MMP,Serine-)
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP28
  entrez: '79148'
- word: (Cathepsin,MMP,Serine-)
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP25
  entrez: '64386'
- word: (Cathepsin,MMP,Serine-)
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP27
  entrez: '64066'
- word: (Cathepsin,MMP,Serine-)
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP19
  entrez: '4327'
- word: RIPK3
  symbol: RIPK3
  source: hgnc_symbol
  hgnc_symbol: RIPK3
  entrez: '11035'
- word: CK2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2A2
  entrez: '1459'
- word: (Cathepsin,MMP,Serine-)
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP17
  entrez: '4326'
- word: CK2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2A1
  entrez: '1457'
chemicals:
- word: Serine
  source: MESH
  identifier: C047902
- word: Sialic acid
  source: MESH
  identifier: D012794
- word: Ca
  source: MESH
  identifier: D002118
- word: Cavcolin
  source: ''
  identifier: ''
diseases:
- word: cancer
  source: MESH
  identifier: D009369
---
